Search for: "Deas v. Deas" Results 1 - 20 of 784
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Dec 2015, 3:36 pm by Sabrina I. Pacifici
EFF – “A Victory for Privacy and Transparency: HRW v. [read post]
7 Aug 2023, 8:40 am by Delia A. Deschaine
” Helpfully, DEA is asking those who plan to attend the listening sessions to consider the following questions ahead of time: If telemedicine prescribing of schedule III-V medications were permitted in the absence of an in-person medical evaluation, what framework, including safeguards and data, with respect to telemedicine prescribing of schedule III-V medications do you recommend to help the agency ensure patient safety and prevent diversion of controlled… [read post]
8 Apr 2015, 7:04 am by Nate Cardozo
  Related Issues: InternationalSurveillance and Human RightsPrivacyRelated Cases: HRW v. [read post]
14 Dec 2015, 12:21 pm by Mark Rumold
          Files: defendants_responses_to_plaintiffs_interrogatories_1-5.pdfletter_from_kathryn_wyer_to_mark_rumold.pdfRelated Issues: PrivacyRelated Cases: HRW v. [read post]
8 Oct 2010, 9:11 am by FDABlog HPM
An agent may telephone a pharmacy concerning a prescription for a controlled substance in schedules III through V and convey the practitioner’s otherwise valid oral prescription provided the prescriber has specified all required prescription information. 3. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]
26 Jan 2025, 10:00 pm
Signaling a possible future approach to regulating Schedule II-V prescribing via telemedicine in lieu of in-person examinations, on January 17 the DEA issued a notice of proposed rulemaking regarding its next iteration of controlled substance prescribing controls. [read post]